Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $23.1B | -- | -- | $2.74 | -- |
| 01/21/2026 | Q4 | $24.1B | -- | -- | $2.52 | -- |
| 10/14/2025 | Q3 | $23.8B | $24B | $2.12 | $2.76 | -$0.64 |
| 07/16/2025 | Q2 | $22.9B | $23.7B | $2.29 | $2.68 | -$0.40 |
| 04/15/2025 | Q1 | $21.6B | $21.9B | $4.54 | $2.58 | $1.96 |
| 01/22/2025 | Q4 | $22.4B | $22.5B | $1.41 | $2.01 | -$0.60 |
| 10/15/2024 | Q3 | $22.2B | $22.5B | $1.11 | $2.21 | -$1.10 |
| 07/17/2024 | Q2 | $22.3B | $22.4B | $1.93 | $2.70 | -$0.77 |
| 04/16/2024 | Q1 | $21.4B | $21.4B | $1.34 | $2.65 | -$1.31 |
| 01/23/2024 | Q4 | $21B | $21.4B | $1.67 | $2.28 | -$0.62 |
| 10/17/2023 | Q3 | -- | $21.3B | $1.98 | -- | -- |
| 07/20/2023 | Q2 | -- | $21.5B | $1.96 | -- | -- |
| 04/18/2023 | Q1 | -- | $20.9B | -$0.03 | -- | -- |
| 01/24/2023 | Q4 | -- | $20B | $1.33 | -- | -- |
| 10/18/2022 | Q3 | -- | $20B | $1.68 | -- | -- |
| 07/19/2022 | Q2 | -- | $24B | $1.80 | -- | -- |
| 04/19/2022 | Q1 | -- | $23.4B | $1.93 | -- | -- |
| 01/25/2022 | Q4 | -- | $24.8B | $1.77 | -- | -- |
| 10/19/2021 | Q3 | -- | $23.3B | $1.37 | -- | -- |
| 07/21/2021 | Q2 | -- | $23.3B | $2.35 | -- | -- |
| 04/20/2021 | Q1 | -- | $22.3B | $2.32 | -- | -- |
| 01/26/2021 | Q4 | -- | $22.5B | $0.65 | -- | -- |
| 10/13/2020 | Q3 | -- | $21.1B | $1.33 | -- | -- |
| 07/16/2020 | Q2 | -- | $18.3B | $1.36 | -- | -- |
| 04/14/2020 | Q1 | -- | $20.7B | $2.17 | -- | -- |
| 01/22/2020 | Q4 | -- | $20.8B | $1.50 | -- | -- |
| 10/15/2019 | Q3 | -- | $20.7B | $0.66 | -- | -- |
| 07/16/2019 | Q2 | -- | $20.6B | $2.08 | -- | -- |
| 04/16/2019 | Q1 | -- | $20B | $1.39 | -- | -- |
| 01/22/2019 | Q4 | -- | $20.4B | $1.12 | -- | -- |
| 10/16/2018 | Q3 | -- | $20.3B | $1.44 | -- | -- |
| 07/17/2018 | Q2 | -- | $20.8B | $1.45 | -- | -- |
| 04/17/2018 | Q1 | -- | $20B | $1.60 | -- | -- |
| 01/23/2018 | Q4 | -- | $20.2B | -$3.99 | -- | -- |
| 10/17/2017 | Q3 | -- | $19.6B | $1.37 | -- | -- |
| 07/18/2017 | Q2 | -- | $18.8B | $1.40 | -- | -- |
| 04/18/2017 | Q1 | -- | $17.8B | $1.61 | -- | -- |
| 01/24/2017 | Q4 | -- | $18.1B | $1.38 | -- | -- |
| 10/18/2016 | Q3 | -- | $17.8B | $1.53 | -- | -- |
| 07/19/2016 | Q2 | -- | $18.5B | $1.43 | -- | -- |
| 04/19/2016 | Q1 | -- | $17.5B | $1.59 | -- | -- |
Johnson & Johnson reported $24B worth of top line sales in its most recent quarter.
Johnson & Johnson announced earnings per share of $2.12 which represents a miss of analyst forecast a $2.76 per share.
Johnson & Johnson reported $16.7B that represents $6.89 per share over the last quarter.
Johnson & Johnson's earnings are forecast to grow from $5.79 per share to $10.85 per share next year representing an increase of 99.04%.
Johnson & Johnson's next earnings date is January 21, 2026.
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.